The Effect of 21-Days Intranasal Oxytocin on Patients With Post Traumatic Stress Disorder (PTSD)

NCT02336568 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

PTSD

Interventions

DRUG: Oxytoine
DRUG: PLACEBO

Sponsor

Rambam Health Care Campus